AHA, AHIP OpEd: When Your Medication Costs More Than Your Mortgage
“Prescription drug prices are out of control,” wrote AHA President and CEO Rick Pollack and America’s Health Insurance Plans President and CEO Marilyn Tavenner in a Dec. 31 OpEd in The Hill. “The average annual cost for one specialty medication to treat a chronic condition is now more than what most families earn in a year. Big Pharma could solve the problem by committing to more rational and sustainable pricing models. Instead, for the last year, Big Pharma has chosen to point the finger at everyone else, and their decision to engage in a blame game is a tacit admission that drug prices are, in fact, too high.” To read the full column, click here.
Related News Articles
Headline
The Department of Health and Human Services Office of Inspector General Jan. 27 released a bulletin addressing how direct-to-consumer drug programs can sell…
Headline
The Centers for Medicare & Medicaid Services Jan. 27 announced 15 drugs under Medicare Parts D and B selected for the third round of price negotiations.…
Headline
A KFF analysis released Jan. 28 found that Medicare Advantage insurers made nearly 53 million prior authorization determinations in 2024, an increase…
Headline
The AHA Jan. 26 released a white paper on addressing challenges in implementing an advanced explanation of benefits, which requires coordination among multiple…
Perspective
In Elma, Wash., Summit Pacific Medical Center uses innovative approaches to address the region’s significant health challenges, including high rates of chronic…
Headline
The White House released a health care plan Jan. 15 addressing drug prices, health insurance premiums and price transparency efforts. The plan includes…